Vanderbilt University Medical Center
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
Vanderbilt University Medical Center1301 Medical Center Dr
Nashville, Tennessee, 37232
Nashville, Tennessee, 37232
Website : https://www.vanderbilthealth.com/cancer/51486
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.Year | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
Number performed | 15 | 19 | 24 | 39 | 51 |
Medical Director
Name | Phone |
---|---|
Garrett Booth, MD | (615) 936-8958 |
Bhagirathbhai Dholaria, MD, FACP | (615) 936-8422 |
Reena Jayani, MD | (615) 936-8422 |
Adetola Kassim, MD | (615) 936-8422 |
Bipin Savani, MD, MBBS | |
Deva Sharma, MD | (615) 936-8958 |
Physician
Name | Phone |
---|---|
Eden Biltibo, MD | (615) 936-8422 |
Andrew Jallouk, MD | (615) 936-8422 |
James Jerkins, MD | (615) 936-8422 |
Olalekan Oluwold, MD, MPH, MBBS | (615) 936-8422 |
Coordinator
Name | Phone |
---|---|
Brittney Baer, RN | (615) 322-4141 |
Lydia Kranz, RN, BSN | (615) 322-4141 |
Leslie Medor | |
Sarah Mosley | |
Arcola Patterson, RN | (615) 342-4141 |
Joanne Rains | (615) 322-4141 |
Jessica Roberts, RN | (615) 322-4141 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
CAR T-Cell products
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)